8-K ·Filed May 20, 2026

PRLB

Proto Labs Inc
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001443669-26-000028
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine governance filing with no earnings or guidance content. Monitor for future equity grant activity under the expanded plan, but no near-term trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PRLB ▲ +29.16% at T+60d
NEUTRAL call ✓ call won +29.16% · α vs SPY +24.15% · entry $71.13 → $91.87
Entry anchored
May 20, 03:37 PM ET
via exchange tick
T+1d
-1.94%
call -1.94% · α -2.13%
$69.75
settled 5mo ago
T+5d
+4.58%
call +4.58% · α +3.35%
$74.39
settled 4mo ago
T+20d
+13.96%
call +13.96% · α +13.22%
$81.06
settled 4mo ago
T+60d
+29.16%
call +29.16% · α +24.15%
$91.87
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Proto Labs held its 2026 annual meeting on May 19, 2026, where shareholders elected all seven director nominees, ratified Ernst & Young as auditor, approved executive compensation on an advisory basis, selected a one-year frequency for future say-on-pay votes, and approved an amendment to the 2022 Long-Term Incentive Plan increasing the share reserve by 395,000 shares. The plan amendment adds potential dilution of approximately 2.5% to the current share base, but the filing is a routine administrative report with no material financial information disclosed.

Key Facts

  • Shareholders approved an additional 395,000 shares for the 2022 Long-Term Incentive Plan.
  • All seven director nominees were elected with strong support (lowest vote share ~83% for Archie C. Black).
  • Advisory vote on executive compensation passed with ~82% support.
  • Frequency of future say-on-pay votes set to annual.
  • Ratification of Ernst & Young as auditor passed with ~98% support.
  • No departures, no C-suite changes, no financial results reported.

Financial Impact

Additional 395,000 shares authorized for equity awards represents ~2.5% dilution assuming ~15.5M shares outstanding, but no actual grants or issuance have occurred.

dilution

Risk Factors

  • Potential future dilution as shares are granted under the expanded plan.
  • Say-on-pay support at 82% is solid but not overwhelming — watch for proxy advisor concerns in future years.

Market Snapshot

Exchange
NYSE
Sector
Fabricated Structural Metal Products
Analyst Consensus
73% bullish (11 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001443669-26-000028
Document: prlb-20260519.htm0001443669-26-000028
Document: 0001443669-26-000028-index-headers.html0001443669-26-000028
Document: 0001443669-26-000028-index.html0001443669-26-000028
Document: 0001443669-26-000028.txt0001443669-26-000028
4 reports for PRLB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PRLB — sortable, filterable
TypeNow
Jul 31, 2026
9w ago
8-K
BULLISH ★ 7/10
$75.05 $79.74▲ +6.25%▲ +3.26%$94.37 (+25.74%)
May 20, 2026
19w ago
8-K
NEUTRAL ★ 2/10
$71.13 $81.06▲ +13.96%▲ +13.22%$94.37 (+32.67%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$68.17 $74.67▲ +9.54%▲ +6.40%$94.37 (+38.43%)
Apr 8, 2026
25w ago
DEFA14A
NEUTRAL ★ 2/10
$60.51 $67.69▲ +11.87%▲ +3.32%$94.37 (+55.96%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (36h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access